SMEK1 Inhibitors
Chemical inhibitors of SMEK1 include a variety of compounds that can interfere with specific cellular pathways, indirectly leading to the functional inhibition of this protein. Okadaic Acid and Calyculin A, for instance, target the activity of protein phosphatases PP1 and PP2A. By inhibiting these phosphatases, the phosphorylation state within the cell is shifted, potentially resulting in the hyperphosphorylation of proteins that would otherwise be dephosphorylated by these enzymes. Such an altered phosphorylation landscape can prevent SMEK1 from interacting with its substrates or from being properly regulated, thus inhibiting its function.
Furthermore, H-89, as a PKA inhibitor, can alter the phosphorylation of proteins within the SMEK1 pathway, thus indirectly inhibiting its function. Rapamycin, by specifically inhibiting mTOR, disrupts mTORC1 and mTORC2 complexes which may be essential for the localization or regulatory function of SMEK1 within certain signaling pathways. LY294002 and Wortmannin, both PI3K inhibitors, can prevent the activation of downstream targets within PI3K-dependent pathways, which could be crucial for SMEK1's activity. U0126 and PD98059, which inhibit MEK1/2 in the MAPK/ERK pathway, can also lead to SMEK1 inhibition. Triciribine, by selectively inhibiting Akt, can influence SMEK1. SB203580's inhibition of p38 MAP kinase can influence SMEK1's role in stress response pathways, and SP600125's inhibition of JNK can affect SMEK1.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As a potent inhibitor of protein phosphatases PP1 and PP2A, Okadaic Acid can indirectly inhibit SMEK1 by preventing the dephosphorylation of proteins that are required for SMEK1 to exert its function, thus maintaining SMEK1 in an inactive state. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Similar to Okadaic Acid, Calyculin A inhibits protein phosphatases such as PP1 and PP2A. By doing so, it can indirectly inhibit SMEK1 through hyperphosphorylation of proteins that interact with or regulate SMEK1's activity. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
H-89 is an inhibitor of protein kinase A (PKA) and can inhibit SMEK1 indirectly by altering the phosphorylation status of proteins within the SMEK1 pathway, which could prevent SMEK1 from interacting with its substrates or partners. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By specifically inhibiting mTOR, Rapamycin can indirectly inhibit SMEK1 by disrupting mTORC1 and mTORC2 complexes that may be necessary for the proper localization and function of SMEK1 within certain signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
This inhibitor of PI3K can indirectly inhibit SMEK1 by preventing the PI3K-dependent activation of downstream targets that may be involved in the same signaling cascades as SMEK1, thereby inhibiting SMEK1-mediated pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor, can indirectly inhibit SMEK1 by blocking PI3K signaling, which is potentially involved in pathways that regulate SMEK1 activity, resulting in a functional inhibition of SMEK1. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK, which is part of the MAPK/ERK pathway. Inhibition of this pathway can lead to the indirect inhibition of SMEK1 if SMEK1 is acting downstream or in conjunction with this pathway. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
This compound selectively inhibits Akt, which can lead to the functional inhibition of SMEK1 if SMEK1's activity is regulated by Akt-mediated pathways or if Akt phosphorylation is necessary for SMEK1's function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can indirectly inhibit SMEK1 by blocking the MAPK/ERK pathway, a signaling cascade that can influence the activity or localization of SMEK1 within the cell. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAP kinase inhibitor; inhibition of p38 can lead to the functional inhibition of SMEK1 if SMEK1 is involved in stress response pathways regulated by p38 MAPK. | ||||||